Apr 8, 2016

Posted by in Stock Reports | 0 Comments

Significant Insider Selling Activity: Illumina, Inc. (NASDAQ:ILMN), Thermo Fisher Scientific Inc. (NYSE:TMO),Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Significant Insider Selling Activity: Illumina, Inc. (NASDAQ:ILMN), Thermo Fisher Scientific Inc. (NYSE:TMO),Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Illumina, Inc. (NASDAQ:ILMN) saw an insider sell on Apr 05, 2016 that may make shareholders worried. HENRY CHRISTIAN O, EVP & Chief Commercial Officer, sold 2,141 shares at $166.07 a piece. The total sale came to $355,546, leaving the total count to 30,397 shares. Its shares currently owned by company management are 1.20% while institutional investors own about 93.10%. The 6-month change recorded in total insider ownership was -9.48%. On the other side, -0.06% change in total institutional ownership has been reported for the 3-month period.

Moving on to the second insider trade which involved HOOGASIAN SETH H, a Sr. VP, Gen. Counsel & Sec at Thermo Fisher Scientific Inc. (NYSE:TMO) sold 10,000 shares at $141.86 per share to trim the total holding at 36,937 shares. Its shares currently owned by company management are 0.20% while institutional investors own about 91.10%. The 6-month change recorded in total insider ownership was -29.23%. On the other side, -0.38% change in total institutional ownership has been reported for the 3-month period.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) also received some insider trading action as GOLDSTEIN JOSEPH L, who the company’s Director is sold some 2,000 shares at a price of $425.00 per share to the holding that now comprises of 13,000 shares. Its shares currently owned by company management are 1.00% while institutional investors own about 72.10%. The 6-month change recorded in total insider ownership was -16.17%. On the other side, -0.27% change in total institutional ownership has been reported for the 3-month period.

 

 

 

 

 

Comments are closed.